Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rudge

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|February 8, 2011
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assayJulie Ann Edgeworth, Michael Farmer, Anita Sicilia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 13, 2022
Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob diseaseAkin Nihat, Tze How Mok, Hans Odd, et al.
Acta Neuropathologica Communications|November 21, 2013
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseasesLilla Reiniger, Ilaria Mirabile, Ana Lukic, et al.
Dementia and Geriatric Cognitive Disorders Extra|September 11, 2012
Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1Christopher Carswell, Michael Rañopa, Suvankar Pal, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
The cognitive profile of prion disease: a prospective clinical and imaging studyDiana Caine, Renata J Tinelli, Harpreet Hyare, et al.
Acta Neuropathologica|May 28, 2021
Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-β transmissionZane Jaunmuktane, Gargi Banerjee, Simon Paine, et al.
The New England Journal of Medicine|January 19, 2017
Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129Tzehow Mok, Zane Jaunmuktane, Susan Joiner, et al.
Brain : a Journal of Neurology|April 4, 2013
The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studiesAndrew G B Thompson, Jessica Lowe, Zoe Fox, et al.
Brain : a Journal of Neurology|October 1, 2010
Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseasesDurrenajaf Siddique, Harpreet Hyare, Stephen Wroe, et al.
Brain : a Journal of Neurology|August 14, 2015
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 yearsPeter Rudge, Zane Jaunmuktane, Peter Adlard, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|February 8, 2011
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assayJulie Ann Edgeworth, Michael Farmer, Anita Sicilia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 13, 2022
Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob diseaseAkin Nihat, Tze How Mok, Hans Odd, et al.
Acta Neuropathologica Communications|November 21, 2013
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseasesLilla Reiniger, Ilaria Mirabile, Ana Lukic, et al.
Dementia and Geriatric Cognitive Disorders Extra|September 11, 2012
Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1Christopher Carswell, Michael Rañopa, Suvankar Pal, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
The cognitive profile of prion disease: a prospective clinical and imaging studyDiana Caine, Renata J Tinelli, Harpreet Hyare, et al.
Acta Neuropathologica|May 28, 2021
Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-β transmissionZane Jaunmuktane, Gargi Banerjee, Simon Paine, et al.
The New England Journal of Medicine|January 19, 2017
Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129Tzehow Mok, Zane Jaunmuktane, Susan Joiner, et al.
Brain : a Journal of Neurology|April 4, 2013
The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studiesAndrew G B Thompson, Jessica Lowe, Zoe Fox, et al.
Brain : a Journal of Neurology|October 1, 2010
Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseasesDurrenajaf Siddique, Harpreet Hyare, Stephen Wroe, et al.
Brain : a Journal of Neurology|August 14, 2015
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 yearsPeter Rudge, Zane Jaunmuktane, Peter Adlard, et al.
Pageof 7